BRD4 and cancer: Other in vivo findings have shown that the BET inhibitor JQ1 also inhibits TGF-β1-dependent gene expression and BRD4 binding at the Gli1 promoter region in cancer-associated fibroblasts (CAFs), reducing fibroproliferation and cancer cell proliferation [184].